K. Kawaguchi

Characterization of influenza virus variants induced by treatment with the endonuclease inhibitor baloxavir marboxil

S. Cusack, T. Uehara, H. Yamaguchi, 2018, Scientific Reports.

A phase I/II study of cancer peptide vaccine S-288310 in patients with advanced urothelial carcinoma of the bladder

Teruhiko Yoshida, T. Miki, T. Shuin, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Baloxavir Treatment in Adolescents With Acute Influenza: Subgroup Analysis From the CAPSTONE-1 Trial

F. Hayden, T. Uehara, M. Kinoshita, 2020, Journal of the Pediatric Infectious Diseases Society.

Baloxavir Marboxil for Prophylaxis against Influenza in Household Contacts.

H. Ikematsu, F. Hayden, T. Uehara, 2020, The New England journal of medicine.

Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents

F. Hayden, A. Hurt, T. Uehara, 2018, The New England journal of medicine.

Treatment-Emergent Influenza Variant Viruses With Reduced Baloxavir Susceptibility: Impact on Clinical and Virologic Outcomes in Uncomplicated Influenza.

F. Hayden, A. Hurt, T. Uehara, 2019, The Journal of infectious diseases.

Lethal drug interactions of sorivudine, a new antiviral drug, with oral 5-fluorouracil prodrugs.

H. Okuda, T. Nishiyama, T. Watabe, 1997, Drug metabolism and disposition: the biological fate of chemicals.

Baloxavir marboxil in Japanese patients with seasonal influenza: Dose response and virus type/subtype outcomes from a randomized phase 2 study

T. Uehara, T. Ishida, A. Watanabe, 2019, Antiviral research.

Abstract P4-14-26: Phase I expansion of S-222611, a reversible inhibitor of EGFR and HER2, in advanced solid tumors, including HER2-positive breast cancer patients with brain metastases

R. Plummer, E. Frenkel, A. Italiano, 2016 .